Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
158.70
-0.60 (-0.38%)
Apr 1, 2025, 5:24 PM IDT

Novolog (Pharm-Up 1966) Revenue

In the year 2024, Novolog (Pharm-Up 1966) had annual revenue of 2.02B ILS with 23.01% growth. Novolog (Pharm-Up 1966) had revenue of 689.88M in the quarter ending December 31, 2024, with 74.01% growth.

Revenue
2.02B
Revenue Growth
+23.01%
P/S Ratio
0.40
Revenue / Employee
2.12M
Employees
955
Market Cap
813.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.02B378.11M23.01%
Dec 31, 20231.64B135.54M8.99%
Dec 31, 20221.51B252.70M20.13%
Dec 31, 20211.26B121.61M10.73%
Dec 31, 20201.13B129.51M12.90%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 60.26B
Danel (Adir Yeoshua) 2.77B
Kamada 586.24M
Bait Bakfar 103.40M
Ilex Medical 982.96M
BrainsWay 149.39M
SofWave Medical 217.27M
Golden House 47.96M
Revenue Rankings